EARNEST PARTNERS LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-09 5:09 pm Sale |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
EARNEST PARTNERS LLC | 3,304,456 4.100% |
-3,011,909 (-47.68%) |
Filing |
| 2022-02-10 5:37 pm Sale |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
EARNEST PARTNERS LLC | 6,316,365 7.900% |
-415,064 (-6.17%) |
Filing |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
EARNEST PARTNERS LLC | 6,731,429 9.000% |
6,731,429 (New Position) |
Filing |